|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
$3,578
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
RTOG Biospecimen Repository
|
3U24CA114734-08S1
|
$946,151
|
$94,615
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Dual Targeted Nanoparticle therapy for Glioblastoma Multiforme
|
1U43CA182921-01
|
$224,980
|
$224,980
|
GOOMER, RANDAL
|
AVRYGEN CORPORATION
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
$1,621
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
International Case Control Study of Malignant Glioma
|
5R01CA139020-05
|
$1,836,550
|
$1,836,550
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Apoptosis driven by elastase inhibitor: new approach to detection and study.
|
5R21CA178365-02
|
$165,089
|
$165,089
|
DIDENKO, VLADIMIR
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
1R01CA187202-01
|
$636,476
|
$636,476
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Neurocognitive Outcomes Following Proton Beam Radiation Therapy for Treatment of
|
5K07CA157923-04
|
$148,746
|
$148,746
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
1R01CA185402-01
|
$324,033
|
$324,033
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
$11,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
$7,325
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
$22,470
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
$412,011
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
3R01CA166749-02S1
|
$51,202
|
$51,202
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
5R01CA166749-02
|
$309,346
|
$309,346
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Control of cancer and metastasis by endothelial-derived epoxyeicosatrienoic acids
|
5R01CA148633-05
|
$271,769
|
$135,885
|
PANIGRAHY, DIPAK
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme
|
5R44CA136017-05
|
$948,501
|
$948,501
|
XU, KEVIN
|
BEXION PHARMACEUTICALS, INC.
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S5
|
$110,177
|
$1,102
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
|
Combination Therapies for Cancer Treatment
|
5R01CA049248-24
|
$318,393
|
$105,070
|
WAXMAN, DAVID
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Dysregulation of mTORC2 in gliomas
|
5R01CA168700-03
|
$222,812
|
$222,812
|
GERA, JOSEPH
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
1U10CA180821-01
|
$10,540,919
|
$263,523
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S1
|
$228,063
|
$5,702
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S2
|
$264,661
|
$6,617
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S3
|
$16,838
|
$421
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Indirubins: novel anti-invasive and anti-angiogenic drugs for malignant gliomas
|
5R01CA166172-02
|
$355,670
|
$355,670
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MicroRNA128 Regulation of Polycomb Repressor Complexes1 and 2 in Glioblastoma
|
1R01CA176203-01A1
|
$377,225
|
$377,225
|
GODLEWSKI, JAKUB
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
|
5P01CA174645-02
|
$1,244,399
|
$833,747
|
JOLESZ, FERENC
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
5U24CA180918-02
|
$647,864
|
$213,795
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Validation of microRNA Targets in Glioma
|
5R01CA138734-05
|
$341,141
|
$341,141
|
KRICHEVSKY, ANNA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Targeting the Tumor Matrix as Anti-Invasive and Sensitizing Strategy for Glioma
|
5R01CA152065-06
|
$269,487
|
$269,487
|
VIAPIANO, MARIANO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
|
5U24CA160034-04
|
$3,023,578
|
$755,895
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
Broad Institute Center for Cancer Systems Biology
|
5U54CA112962-10
|
$2,106,778
|
$526,695
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
Integrative modeling of gene expression into GWAS of glioma
|
1R03CA182937-01A1
|
$81,250
|
$81,250
|
MICHAUD, DOMINIQUE
|
BROWN UNIVERSITY
|
|
Nanosystems Biology Cancer Center 2
|
5U54CA151819-05
|
$2,357,460
|
$589,365
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
(PQC5) Detecting small clusters of tumor cells with a PTPmu probe
|
5R01CA179956-02
|
$598,485
|
$598,485
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S1
|
$74,051
|
$12,589
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S2
|
$29,166
|
$4,958
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S3
|
$145,188
|
$24,682
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-24
|
$4,748,649
|
$807,270
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
1U10CA180853-01
|
$1,188,450
|
$59,423
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Akt-EphA2 Crosstalk in Glioma Invasion
|
5R01CA152371-05
|
$316,002
|
$316,002
|
WANG, BINGCHENG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Nanoconjugate based on polymalic acid for brain tumor treatment
|
5U01CA151815-05
|
$457,921
|
$457,921
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
1U10CA180884-01
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
1U10CA180886-01
|
$26,616,497
|
$5,988,712
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S1
|
$79,593
|
$17,908
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S2
|
$208,457
|
$46,903
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S3
|
$229,232
|
$51,577
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S4
|
$1,163,256
|
$261,733
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S5
|
$1,543,656
|
$347,323
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S6
|
$265,465
|
$59,730
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
Total relevant funding to Brain for this search: $177,237,117
|